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ARTICLE
Biochemical mechanisms determine the functional
compatibility of heterologous genes
Andreas Porse1, Thea S. Schou1, Christian Munck1, Mostafa M.H. Ellabaan1 & Morten O.A. Sommer 1
Elucidating the factors governing the functional compatibility of horizontally transferred
genes is important to understand bacterial evolution, including the emergence and spread of
antibiotic resistance, and to successfully engineer biological systems. In silico efforts and
work using single-gene libraries have suggested that sequence composition is a strong barrier
for the successful integration of heterologous genes. Here we sample 200 diverse genes,
representing >80% of sequenced antibiotic resistance genes, to interrogate the factors
governing genetic compatibility in new hosts. In contrast to previous work, we ﬁnd that GC
content, codon usage, and mRNA-folding energy are of minor importance for the compat-
ibility of mechanistically diverse gene products at moderate expression. Instead, we identify
the phylogenetic origin, and the dependence of a resistance mechanism on host physiology,
as major factors governing the functionality and ﬁtness of antibiotic resistance genes. These
ﬁndings emphasize the importance of biochemical mechanism for heterologous gene com-
patibility, and suggest physiological constraints as a pivotal feature orienting the evolution of
antibiotic resistance.
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A distinct feature of prokaryotes is their ability to sharegenetic material via horizontal gene transfer1. Such open-source evolution provides rapid access to the genetic
innovations that continuously shape bacterial genomes2. The
transfer of genes between bacteria happens primarily via trans-
ferrable genetic elements such as plasmids, phages, or direct DNA
uptake (transformation)3. Although such transfer events are
believed to occur frequently in nature, the fundamental forces
governing the establishment and maintenance of successfully
transferred genes are poorly understood2,4. Because foreign genes
may lose functionality or impose a high biological cost in new
hosts, this gap in our understanding also limits current synthetic
biology efforts focused on engineering novel functions into bio-
logical systems5,6.
From computational studies of sequenced genomes, the ten-
dency of a gene to be transferred has been inferred to depend
mainly on ecological and phylogenetic factors1,4. As physical
proximity of donor and recipient bacteria is generally required for
transfer, ecology has been suggested as a strong dissemination
barrier4. However, the broad host range of some transfer
mechanisms, and the ubiquitous presence of antibiotic resistance
genes across environments, suggest that ecological barriers are
largely governed by functional constraints7,8. Indeed, numerous
studies reveal a functional bias of transferred gene categories, with
genes encoding largely independent products, e.g., those involved
in secondary metabolism or virulence, being transferred more
often than genes encoding highly interactive proteins involved in
transcription and translation9–12. Furthermore, metagenomic
analyses of DNA from different environments suggest that genes
involved in antibiotic resistance are more conﬁned by phylogeny,
indicating that genomic factors are important for the acquisition
or maintenance of foreign genetic material4,13,14. In support of
this idea, in silico studies have shown a bias in the nucleotide
composition of transferred genes in relation to the recipient
genome, and suggest that sequence parameters inﬂuence suc-
cessful gene integration15–17. Speciﬁcally, a role of the codon
usage and GC content on the functional integration of acquired
genes has been inferred due to the potential role in gene
expression and ﬁtness18,19. Upon successful transfer, host com-
patibility and selection are crucial for the long-term persistence of
newly acquired genetic material, as costly genes will eventually be
lost through purifying selection20–25.
Experimental studies characterizing the phenotypic effects of
synonymous sequence variation have largely focused on a limited
set of phenotypes and most current data are obtained from
ﬂuorescent protein expression26–28. However, recent work by
Kacar and Garmendia et al. showed an increased ﬁtness cost of
replacing the elongation factor Tu (a highly conserved protein
involved in translation) with its distant homologs in Escherichia
coli, and similar results have been obtained by Lind et al. when
replacing ribosomal subunits in Salmonella typhimurium29,30.
While the ﬁtness cost of expressing these core translational genes
could not be attributed to differences in sequence composition,
Amorós-Moya et al. showed that sub-optimal codon usage of a
highly expressed chloramphenicol acetyl transferase resistance
gene resulted in lower resistance levels and a decrease in overall
host ﬁtness31. Although existing studies provide interesting clues
on the relation among sequence composition, gene expression,
and ﬁtness, the relevance of these ﬁndings regarding the func-
tionality of diverse naturally occurring accessory genes involved
in antibiotic resistance is not clear.
Antibiotic resistance genes are ubiquitously present on mobile
genetic elements that allow their extensive dissemination among
bacteria3. Given the stagnation in antibiotic discovery, the
increasing prevalence of multidrug resistant bacteria constitutes
an urgent threat to public health that motivates a deeper
understanding of the forces governing the dissemination and
long-term maintenance of antibiotic resistance genes32–34.
Antibiotic resistance is conferred through ﬁve major mechan-
isms: (i) enzymatic drug inactivation, (ii) active drug efﬂux, (iii)
modiﬁcation of drug target, (iv) replacement of the drug target
with a resistant variant, and (v) regulatory shifts towards a more
resistant phenotype35. The diversity of mechanisms, through
which antibiotic resistance is achieved, makes antibiotic resistance
genes a valuable model system for investigating the factors that
may affect the functional compatibility of transferable genes in
general.
In this study, we employ a synthetic bottom-up approach by
sampling a broad sequence space of 200 diverse open reading
frames annotated as antibiotic resistance genes. Via experimental
proﬁling of these genes, we discover that resistance mechanisms
and the phylogenetic relatedness of donor and recipient species
act together as important determinants of gene functionality and
ﬁtness cost. Consequently, we suggest that these effects dominate
the potential transfer barriers imposed by sub-optimal sequence
composition of heterologous genes.
Results
200 genes representatively sampled from major databases. By
clustering all genes of major publicly available antibiotic resis-
tance gene databases, and selecting the most abundant genotypes,
we obtained 200 genes for DNA synthesis (Methods, Supple-
mentary Fig. 1a and Supplementary Data 1). The selected clusters
represented the most abundant genes in resistance gene databases
(>80%, Supplementary Fig. 1a) and accounted for 98% of the
total data set homologs in general sequence databases (NCBI NT
and Genomes) (Supplementary Fig. 1b).
The 200 selected genes vary widely in resistance mechanisms,
targeted drug classes, and phylogenetic dissemination (Fig. 1,
Supplementary Data 1). In total, 64% of the selected genes were
associated exclusively with Gram-negative organisms, and of the
remaining genes, 13% were found in Gram-positive organisms,
and 10.5% were found in both Gram-negative and Gram-positive
organisms (Fig. 1c). However, 12.5% of the genes had not been
associated with a particular host organism (mostly genes found
via metagenomic functional selections). The selected genes were
annotated to confer resistance to 11 distinct drug classes via 23
distinct biochemical functions that can be divided into ﬁve major
mechanistic categories based on their Resfam annotations (Fig. 1a,
b)36. In addition to genes annotated to confer resistance towards
known drug classes, genes annotated to confer antibiotic
resistance but without deﬁned antibiotic resistance proﬁles were
included as a consequence of their high abundance in the public
antibiotic resistance databases. All of these genes were annotated
as having regulatory or efﬂux functions but were not associated
with speciﬁc drug classes in the literature (Supplementary
Data 1).
Functional characterization of putative resistance genes. The
200 selected genes were cloned in a low-expression setup in E. coli
MG1655 (Supplementary Fig. 1). All genes were subjected to 20
phenotypic tests and growth rate measurements. Speciﬁcally, the
resistance towards 20 antibiotics comprising 12 chemical classes
was assessed. A gene was considered a functional resistance gene
if it conferred a resistance phenotype of at least a twofold increase
in the minimal inhibitory concentration (MIC) compared to that
of E. coli MG1655 carrying the empty vector (Supplementary
Table 1). Clones displaying a resistance phenotype were subjected
to growth rate assessments under non-selective conditions and
further antibiotic susceptibility testing in a range from 2- to 30-
fold the WT MIC (Fig. 2).
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Whereas only 32% of the 200 tested genes could be identiﬁed in
E. coli genomes deposited in NCBI’s RefSeq database, 63% of the
genes displayed at least one resistance phenotype in E. coli. The
resistance phenotypes were distributed unequally among the drug
classes, with genes annotated to confer resistance towards
tetracyclines, sulfonamides, β-lactams, and ﬂuoroquinolones
having a high proportion (>80%) of functional variants. By
contrast, D-ala ligases, which confer resistance to D-cycloserine in
E. coli, as well as genes annotated to confer resistance towards
polymyxins or multiple drug classes, showed the lowest
proportion of functional genes in our experimental setup (Fig. 2,
Supplementary Data 1). Genes conferring resistance towards
β-lactams, aminoglycosides, chloramphenicol, and trimethoprim
showed the highest average levels of resistance, whereas those
conferring resistance towards ﬂuoroquinolones and D-cycloserine
displayed the lowest average increase in resistance compared to
the susceptible WT (Fig. 2). This difference in resistance level
between drug classes was statistically signiﬁcant (ANOVA, P<
0.001). We further investigated if the level of resistance could be
attributed to differences in the codon adaptation index (CAI), GC
content or mRNA-folding energy; however we could not detect
any signiﬁcant correlations between these sequence parameters
and the resistance level for the total data set nor within resistance
classes (Supplementary Fig. 3).
Sequence composition is not a major functional barrier. As
68% of the tested genes from our data set have not yet been
identiﬁed in sequenced E. coli genomes, our data set is well suited
for studying factors relevant to the functionality of resistance
genes evolved in a foreign genetic context. The selected genes
varied widely in their base composition (Fig. 3), which has pre-
viously been hypothesized to affect functional expression and
successful gene transfer16,18,19.
The codon usage of an incoming gene might inﬂuence its
protein expression and it is generally believed that the CAI is
important for heterologous gene integration18,26,37,38. Surpris-
ingly, we found that the average E. coli CAI of functional
resistance genes was slightly lower compared to that of the non-
functional genes (Mann–Whitney U-test, P = 0.014; Fig. 3a). Yet,
we found no signiﬁcant difference in the average GC content
between the functional and non-functional genes
(Mann–Whitney U-test, P = 0.12) (Fig. 3b). To investigate
whether interactions between these and other parameters would
inﬂuence the outcome of our analysis, we built a multivariate
logistic regression model (Supplementary Table 2). The inclusion
of GC content did not signiﬁcantly change the predictive power
of the model compared to CAI alone (P = 0.70), suggesting that
the effect of the CAI was not governed by the GC content
(Fig. 3d). The folding energy of the N-terminal of a transcript
may also inﬂuence gene expression26,28,39, however, N-terminal
mRNA-folding energy did not predict functionality, nor resis-
tance level of the functional genes, in our logistic regression
model (Fig. 3c, Supplementary Fig. 3 and Supplementary
Table 2).
Although gene functional compatibility exhibited little depen-
dence on sequence composition, it may affect the ﬁtness cost in
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new hosts. As a proxy for ﬁtness, we measured the growth rate of
E. coli expressing each of the functional resistance genes (Fig. 2).
Compared to E. coli carrying the empty expression vector, the
impact of expressing a resistance gene on the growth rate ranged
from a slight increase to more than a 30% decrease in growth rate
(Fig. 2 and Supplementary Fig. 4).
The reduced growth rate resulting from expression of a
resistance gene differed signiﬁcantly between the drug classes to
which the gene conferred resistance (one-way ANOVA, P>
0.001; Fig. 2), but the impact on growth did not differ between
mechanistic categories (one-way ANOVA, P = 0.38; Supplemen-
tary Fig. 5). The gyrase-protecting qnr ﬂuoroquinolone resistance
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genes showed exceptionally low costs compared to other
resistance classes, especially the D-alanine–D-alanine ligases.
These confer D-cycloserine resistance in E. coli through target
replacement, and had a high negative impact on growth rates
(Fig. 2).
Contrary to current thinking, some antibiotic resistance genes
from the qnr and dfr families were slightly advantageous to E. coli
in the absence of antibiotic selection (Fig. 2). We detected
beneﬁcial growth patterns of qnrA as well as qnrS1, which are
found, for example, in Shigella and Salmonella species that are
closely related to E. coli, but not for the qnr genes found in more
distantly related species. Despite the observed trade-off between
resistance level and growth rate for target-modifying genes (r =
0.62, P = 0.04), this was not the case for efﬂux mediators (r
= –0.59, P = 0.12), resistant targets (r = −0.61, P = 0.06) and genes
belonging to the drug-modifying mechanistic class (r = 0.02, P =
0.84; Supplementary Fig. 6).
It has previously been recognized that gene level parameters
such as the CAI and GC content of codon-scrambled genes can
inﬂuence host ﬁtness when expressed in E. coli26,27. E. coli
expressing the trimethoprim resistance gene dfrG of the
dihydrofolate (dfr) family, originating from Staphylococcus
aureus, displayed a lower growth rate compared to E. coli
expressing dfr genes of Gram-negative origin (Fig. 2). Indeed, the
dfrG gene had a low GC content (32%) and CAI (0.17), which we
hypothesized could negatively inﬂuence the growth of E. coli. To
test whether base composition could be optimized to decrease the
growth reduction imposed by dfrG, we synthesized a codon-
optimized variant with a higher GC content (55%) and CAI
(0.66). However, this variant did not show a signiﬁcant growth
improvement compared to the wild-type dfrG gene when
expressed in E. coli (Mann–Whitney U-test, P = 0.1; Supplemen-
tary Fig. 7), suggesting that factors beyond the nucleotide
sequence are responsible for the differential cost.
To assess the general trend in our data set, we investigated the
correlations between growth rate effects and the CAI, GC content,
N-terminal mRNA-folding energy, and gene length (Fig. 4).
Although there was a tendency towards higher growth rates for
genes with an increasing CAI, in contrast to previous studies on
sequence variants, including codon-scrambled gfp26,27, we found
no signiﬁcant correlation between these individual sequence
parameters and the growth rate of E. coli for our diverse set of
antibiotic resistance genes.
A multiple linear regression model of our growth data against
the CAI, GC content, N-terminal mRNA-folding energy, and
gene lengths explained virtually no variation in the growth rate
(R2 = −0.01, P = 0.6; Supplementary Table 3). This result indicated
that other factors dominate the potentially minor growth effects
imposed by the base and codon composition in our data set.
Resistance mechanism is a major determinant of gene com-
patibility. The functional compatibility of a gene in a new host
may depend on its interaction with speciﬁc components of host
physiology and metabolism9. Antibiotic resistance genes mediate
their phenotype through a wide range of cellular interactions,
with some mechanisms being dependent on speciﬁc host struc-
tures, e.g., ribosomal structure or the cell envelope for target
modifying and efﬂux mechanism respectively, whereas drug
modifying enzymes act directly on the antibiotic compound35.
Although we observed a small signiﬁcant difference in the
proportion of functional genes for different targeted drug classes
(χ2, P = 0.031), we also noted that genes annotated to confer
resistance to a speciﬁc drug class were frequently dominated by
speciﬁc resistance mechanisms (Fig. 1b)40. Accordingly, the
mechanistic category of a gene was far better at predicting the
functionality of a gene transferred to E. coli (χ2, P< 0.001) than the
targeted drug class alone. This result suggested that certain
resistance mechanisms are easier to integrate into a novel host
physiology than others (Fig. 5a and Supplementary Table 2). The
highest proportion of functional genes was found among the drug-
modifying enzymes, including the β-lactamases and aminoglyco-
side transferases, with most genes conferring high levels of
resistance (Fig. 5a), and this distribution was not signiﬁcantly
biased by the phylogenetic afﬁliation of these genes (χ2, P = 0.08) or
whether they had previously been identiﬁed in E. coli (χ2, P = 0.77).
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By contrast, genes conferring resistance through efﬂux and
regulatory mechanisms were least likely to function in E. coli, in
which only 28.5% and 10% of genes displayed resistant phenotypes,
respectively. These ﬁndings are consistent with the hypothesis that
genes involved in limited cellular interactions are more likely to be
functionally compatible in a new host9.
Phylogeny affects ﬁtness of cell-interacting resistance genes. If
the activity of a gene product is detrimental for functional genetic
integration due to suboptimal physiological interactions, we
would expect the phylogenetic relatedness of the donor and
recipient species to inﬂuence the functional compatibility and
ﬁtness cost of newly acquired genes. This hypothesis was sup-
ported by the fact that the deviation in GC content from the E.
coli average (50.8% GC) was a stronger, although still not sig-
niﬁcant, predictor of the growth reduction resulting from gene
expression (r = 0.16, P = 0.07; Supplementary Fig. 8) compared to
the absolute GC content (Fig. 4b). As GC content varies among
phylogenetic groups, this trend could be a proxy for the cellular
environment in which a gene has evolved, rather than a direct
effect of sequence composition (Supplementary Fig. 9). Indeed, a
higher average growth rate of E. coli was observed for genes
afﬁliated with Gram-negative organisms compared to those that
were exclusively associated with in Gram-positive organisms or
both (Supplementary Fig. 10. Mann–Whitney U-test, P = 0.03).
To further investigate the basis of the ﬁtness costs of gene
expression, we derived a distance measure based on the average
16S rRNA sequence identity between E. coli and the genomes in
which the gene has been identiﬁed. Using this 16S rRNA-based
evolutionary distance measure, we found a correlation between
the cost of a gene and the relatedness of its genomic context to E.
coli (r = 0.29, P = 0.003). Whereas the relative burden of
expressing drug-modifying enzymes was independent of phylo-
genetic relatedness of the typical hosts of a gene to E. coli (r =
0.04, P = 0.56; Fig. 5c), we found the main drivers of this
correlation to be the genes that directly interact with cellular
components (r = 0.74, P< 0.001; Fig. 5c). This correlation was not
biased by differences in cell-interacting mechanistic categories
(ANOVA, P = 0.93; Fig. 6), targeted drug classes (ANOVA, P =
0.57) or phylogenetic groups (ANOVA, P = 0.23; Supplementary
Fig. 11). However, the effects were most pronounced within the
target replacing and target modifying mechanistic classes, and for
genes afﬁliated with Proteobacteria and Actinobacteria (Fig. 6 and
Supplementary Fig. 11). These results suggests a trade-off
between adaptation towards one host and being broadly
functional across phylogeny, which is further supported by the
higher cost of genes disseminated across Gram-positives and
Gram-negatives (Supplementary Fig. 10).
While there was an unequal distribution of functional genes
among Gram-classes (χ2, P = 0.002), the phylogenetic afﬁliation,
measured as the average 16S rRNA-based distance between
genomes harboring the gene, was not signiﬁcantly correlated with
gene functional compatibility when all genes in our data set were
considered (Mann–Whitney U-test, P = 0.84). Although a bigger
difference was observed when cell-interacting genes were
considered in isolation, this difference was still not signiﬁcant
(Mann–Whitney U-test, P = 0.23; Fig. 5d). However, when
excluding native E. coli genes (Supplementary Table 4), a highly
signiﬁcant dependence of functionality on phylogenetic distance
for cell-interacting proteins (Mann–Whitney U-test, P< 0.001),
but no change for drug-interacting resistance mediators
(Mann–Whitney U-test, P = 0.57), was observed. For this subset
of genes, the effect of phylogenetic differences was dominated by
genes conferring resistance through target replacement
(Mann–Whitney U-test, P = 0.031) and efﬂux mechanisms
(Mann–Whitney U-test, P = 0.015). However, while the Gram-
class afﬁliation was not a signiﬁcant predictor of functionality for
efﬂux, target replacing and regulatory genes (χ2, P> 0.05), genes
originating from Gram-negatives were signiﬁcantly overrepre-
sented in functional target-modifying resistance mediators (χ2, P
= 0.005). These observations further support the importance of
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resistance mechanism and genomic relatedness for gene func-
tional compatibility.
Discussion
To better understand the factors underlying functional compat-
ibility and the ﬁtness cost of genes in new hosts, we assessed a set
of diverse antibiotic resistance genes spanning a wide range of
sequence compositions and biochemical mechanisms. We found
that a substantial proportion of genes, not previously observed in
E. coli, were functional despite huge sequence deviations, in the
CAI and GC content, from the E. coli genome average. Interest-
ingly, we found that sequence composition, including the CAI, N-
terminal mRNA-folding energy, and GC content, was a poor
predictor of functional compatibility and ﬁtness cost (Figs. 3 and
4). Previous studies have shown that the expression level of
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codon-randomized gfp variants is mainly affected by the N-
terminal mRNA-folding energy; however, strong negative effects
of mRNA folding are expected to be counter selected in naturally
occurring genes, and we found no signiﬁcant correlation with this
parameter and functionality in our diverse gene set26,39. Although
we did not assess the effect of sequence composition on expres-
sion levels directly, our results suggest that gene expression is not
trivially linked to phenotypic output as is the case for ﬂuorescent
proteins (Supplementary Fig. 2)26. By virtue of resistance phe-
notypes, we were able to measure end-point functionality directly
to avoid indirect, e.g., protein-level, measurements that might not
reﬂect correct phenotypic integration.
Using antibiotic resistance genes as a model for transferable
accessory genes, we experimentally showed that the mechanism
of the gene product is more important for its functional com-
patibility than the gene sequence composition (Fig. 5a). The
results obtained for the antibiotic resistance genes included here
are likely to apply more broadly to horizontal gene transfer, and
our experimental results support the “complexity hypothesis”
originally proposed by Jain et al., which state that highly inter-
active gene products are less likely to undergo horizontal
transfer9,41,42. Although we did not assess protein interactions
directly, we observed that genes encoding regulators and efﬂux
pumps, which are dependent on regulatory networks or cell
envelope structures, were the least likely to function when
expressed in E. coli compared to genes encoding enzymes that act
directly on the drug (Fig. 5a). This result signiﬁes that the extent
of physiological decontextualization dictates the likelihood of
selection following gene transfer.
While the trend towards higher costs of target-modifying
mediators conferring high-level resistance might be expected, the
lack of, and even opposite tendencies, observed for the remaining
mechanistic classes, suggests that high resistance and low ﬁtness
cost might not be opposing features (Supplementary Fig. 6).
The biological cost of functionally expressing a new gene is an
important factor that potentially determines the reversal of
antibiotic resistance upon cessation of antibiotic use22. Fitness
effects are believed to affect the long-term success of gene transfer
events as well as the robustness of engineered biological systems,
and the origins of these costs have been suggested to stem from
suboptimal sequence composition18,43,44. Notably, in our setup of
moderate expression, our growth measurements did not detect a
signiﬁcant inﬂuence of the sequence-level parameters previously
suggested to inﬂuence the growth rate of E. coli expressing het-
erologous proteins26,27. These studies employed libraries of lower
or similar sequence-level diversity compared to our data set, albeit
with a narrow mechanistic focus (GFP and ɸ29 DNAP), and
observed that the CAI and GC content affected the growth rate of
E. coli26,27. Yet, in line with our observations, Knöppel and Lind
et al.45 were unable to measure a signiﬁcant ﬁtness effect of
parameters such as GC content and length of random DNA
inserts, containing a variable number of open reading frames of
unknown functions, when expressed from a single copy on the
chromosome45. However, we acknowledge that these effects exist
and may be measured by more sensitive ﬁtness assays or at higher
expression levels than the ones used here. Compared to the linear
inﬂuence on the growth rate of E. coli expressing gfp and ɸ29
DNA polymerase genes within the narrow GC range
(40.4–53.7%) observed by Raghavan et al.27, our data suggest that
the possible effect of GC content is non-linear, and that the
deviation from the host genome is more important than the
absolute GC content (Fig. 4b and Supplementary Fig. 8).
While previous studies have found a correlation between ﬁt-
ness and evolutionary distance for homologs of E. coli genes
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involved in translation29,30, we show that these effects are also
evident for accessory genes with non-essential and diverse func-
tionalities, which may contribute to the phylogenetic barriers
more generally observed for horizontal gene transfer1,13,46. These
ﬁtness effects correlated with the relatedness of the donor and
recipient species and were independent of sub-mechanistic- and
phylogenetic categories (Fig. 6 and Supplementary Fig. 11).
Interestingly, although phylogenetic distance was a much stron-
ger predictor of growth inﬂuence than the deviation in GC
content, the correlation between GC deviation and phylogenetic
distance might explain the limited deviation in GC content
observed for transferred genes and their recipient genomes
(Supplementary Fig. 9)15. However, by demonstrating the
dependence on cellular interactions, and showing that GC opti-
mization of the dfrG gene did not improve its cost, GC content
may be a confounder rather than the cause of the ﬁtness effects
observed here.
We found that sequence-level properties have a limited impact
on heterologous gene ﬁtness and function and are therefore
unlikely to be the dominant causal factors conﬁning genes within
speciﬁc phylogenies. Instead, we show that biochemical
mechanisms have strong impacts on heterologous gene ﬁtness
that are proportional to the phylogenetic distance to its cus-
tomary host. The notion that the functional compatibility of cell-
interacting proteins is dependent on phylogenetic relationships
supports a shift in focus away from sequence composition and
metabolic constraints as limiting factors in horizontal gene
transfer. Interestingly, the positive effects observed for certain
members of the dfr and qnr families, implicated in DNA gyrase
protection and folate metabolism, might even enhance their
persistence in the absence of antibiotic selection. However, this is
only true for gene variants acquired from closely related species
and these ﬁtness effects likely depend on the environmental
conditions; e.g., the growth medium.
Importantly, our data suggested that antibiotic resistance genes
interacting directly with the drug are more likely to function and
be maintained when transferred to a new host. Historically, drug-
interacting resistance mechanisms, e.g., utilized by aminoglyco-
sides, chloramphenicol and β-lactam resistance genes, have
emerged faster following the introduction of the drug class in
question, compared to, e.g., macrolide and vancomycin resis-
tance, which are mediated largely through modiﬁcation of the
cellular targets47. For aminoglycosides, drug-modifying genes
were detected regularly since the late 1940s, whereas ribosome-
modifying methyltransferases were ﬁrst detected in the early
2000s48.
We believe that the detailed phenotypic information on indi-
vidual resistance genes obtained here will be an important
resource for ranking the risk of resistance genes and predicting
their evolution against existing and future drugs34,49. However,
knowledge on antibiotic use, co-selection, regulatory, or com-
pensatory interactions in a range of hosts and growth conditions
is needed for more accurate predictions50. Coupling our ﬁndings
to factors such as drug usage and ecology of pathogens may allow
the construction of predictive models to help guide rational drug
usage and development of novel drug classes that are less sus-
ceptible to resistance development34. Finally, the concepts derived
in this study may also guide metabolic engineering or synthetic
biology efforts when heterologous proteins are needed to engineer
any kind of robust biological system5,6.
Methods
Database construction and gene synthesis. All resistance gene entries from the
ARDB, CARD and Lahey Clinic β-lactamase databases (accessed December 2014)
and functional selection studies were downloaded36,51–54. A total of 4253 unique
sequences were obtained after clustering at 99% nucleotide identity using CD-HIT
software55, and these sequences were further clustered at 80% identity resulting in
839 gene clusters. These clusters were ﬁrst sorted according to the average number
of BLAST hits obtained in NCBI to include the most abundant genes and then
sorted on cluster size to limit the inclusion of housekeeping genes; that are often
conserved and occur in small clusters. The 200 largest clusters were selected based
on the modal sequence length of each cluster. Trimming was performed using
GeneMarkS to only include the longest open reading frame of each sequence56.
Due to synthesis and cloning limitations, genes longer than 1970 bp were excluded,
and Xbal and AscI sites were synonymously removed by manual sequence
inspection. Two primer binding sites for ampliﬁcation of the entire gene and a
unique barcode were added to each of the 200 sequences (Supplementary Fig. 2).
Finally, the sequences were ordered as gBlocks through Integrated DNA Tech-
nologies (IDT, Coralville, Iowa, USA). All genes and the data obtained for each
functional gene are available in Supplementary Data 1.
Gene dissemination and genomic context analysis. To assess gene association
with sequenced genomes, BLAST comparisons were performed at a 95% identity
alignment cut-off, and validated through EMBOSS Matcher pairwise alignment,
against NCBIs RefSeq database (67,704 entries; last performed October 2016). The
rarefaction analysis of nucleotide databases (Supplementary Fig. 1b) was performed
at a 90% identity and 90% coverage cut-off against the NCBI nucleotide and
genomes databases. To quantify the dissemination distance of those antibiotic
resistance genes with respect to E. coli, we chose one representative 16S rRNA from
each genus carrying each ARG in RefSeq. The host distance was then calculated
using EMBOSS Matcher pairwise alignment between E. coli 16S rRNA and
representative 16S rRNA for the ARG-carrying genomes and reported as the
percent mismatches in the total alignment of the E. coli reference 16S rRNA gene.
Cloning and expression of gene library. The pZAT vector backbone (Supple-
mentary Fig. 2) was derived from the medium-copy p15A-based pZA21 vector57 by
exchanging the resistance marker with the Sh ble Zeocin resistance gene (Thermo
Fisher Scientiﬁc, Waltham, MA, USA) and inserting the low/medium strength
BBa_J23110 promoter of the iGEM parts registry (http://parts.igem.org). This
backbone was PCR ampliﬁed using primers 5′-AATTTGGCGCGCCCATCAAA-
TAAAACGAAAGGC-3′ and 5′-AATTTTCTAGATCTCCTCTTTAATGCTCGC-
3′ to create Xbal and AscI digestible overhangs. The PCR product (25 µL) was
subsequently treated with 0.5 µL DpnI restriction enzyme (Thermo Fisher) over-
night (O/N) at 37 °C to remove residual template and subsequently PCR puriﬁed
(NucleoSpin Gel and PCR Clean-up kit from Macherey-Nagel, standard protocol).
In 200 individual reactions, the vector backbone was combined with each synthetic
gene block in a reaction containing Xbal and AscI restriction enzymes (Thermo
Fisher). The reactions were incubated at 37 °C for 1 h, followed by heat inactivation
of the enzymes at 80 °C for 20 min. Subsequently, the 20 µL reactions were ligated
by adding 0.5 µL T4 ligase and 3 µL ATP (5 mM) and incubated at room tem-
perature O/N. The 5 µL ligation product was used to transform 50 µL E. coli
MG1655 (the same strain was previously used and sequenced in Munck et al.58)
chemically competent cells followed by recovery at 37 °C for 3 h. Transformed cells
were selected on Zeocin-containing plates (40 µg/ml), and correct insertion of gene
blocks was veriﬁed by colony PCR and subsequent Sanger sequencing using pri-
mers 5′-TATGCCGATATACTATGC-3′ and 5′-AAGCACTTCACTGACACC-3′.
Antibiotic susceptibility testing. The minimal inhibitory concentration of all 20
included antibiotics was measured for all library clones as well as E. coli MG1655
carrying the empty vector backbone (pZAT). One colony of each clone was
inoculated in 180 µL LB/well (with 40 µg/ml Zeocin added for backbone selection)
for overnight (O/N) pre-culturing at 37 °C. Ninety-six-well plates were prepared
with 100 µL MHB2 medium (Sigma) per well, containing the respective antibiotics,
at concentrations 2×, 5×, 10×, and 30× the MIC of E. coli MG 1655/pZAT (Sup-
plementary Table 1). Three replicate plates were inoculated with 5·105 cells and
incubated for 18 h at 37 °C with shaking at 250 rpm (Titramax 1000, Heidolph).
Endpoint optical density (OD) was measured at 600 nms (Synergy H1, BioTek),
and the MIC was deﬁned as the highest concentration with less or similar absor-
bance as the E. coli MG1655/pZAT (negative control) subjected to the same
antibiotic concentration.
Growth rate measurements. The growth rate of each functional clone was
measured as the maximum increase in OD over time during exponential growth.
Individual colonies were picked and placed onto a pre-inoculation plate and grown
for 2–3 h with shaking at 37 °C before inoculation of the ﬁnal measurement plate.
Breathe-Easy (Sigma-Aldrich) ﬁlm was applied to minimize evaporation during
measurements. OD measurements were conducted in 96-well plates containing
150 µL LB medium per well by the ELx808 plate reader (BioTek, USA). OD at 600
nms was measured over 5-min intervals for a maximum of 16 h, and the plates
were incubated at the medium shaking setting at 37 °C between measurements.
Sequence parameters and statistical analysis. All statistical analyses were per-
formed using R (version 3.1.1). Sequence composition data were obtained using the
native functions of Biopython (version 1.70)59. The mRNA-folding energy was
calculated for 35 nt up- and downstream the start codon of each gene using the
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RNAfold web server (http://rna.tbi.univie.ac.at/). The non-parametric
Mann–Whitney U test was used to compare sample means, and a χ2 test was used
when frequencies were assessed. Spearman’s rank correlations were performed to
assess the strength of associations between two continuous variables. When the
inﬂuence of multiple variables was assessed simultaneously, a generalized linear
model was ﬁtted to binary response variables (glm function in R), and a multiple
linear regression was ﬁtted (lm and anova functions in R) to continuous response
data.
Data availability. The authors declare that all the relevant data are provided in this
published article and its Supplementary Information ﬁles, or are available from the
corresponding author on request.
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